These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7071107)

  • 61. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lyophilization of polyethylene glycol mixtures.
    Amin K; Dannenfelser RM; Zielinski J; Wang B
    J Pharm Sci; 2004 Sep; 93(9):2244-9. PubMed ID: 15295785
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose.
    Palmer D; Levina M; Douroumis D; Maniruzzaman M; Morgan DJ; Farrell TP; Rajabi-Siahboomi AR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():174-80. PubMed ID: 23314492
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicentre patch test study of air-oxidized ethoxylated surfactants.
    Matura M; Bodin A; Skare L; Nyrén M; Hovmark A; Lindberg M; Lundeberg L; Wrangsjö K; Karlberg AT
    Contact Dermatitis; 2004 Oct; 51(4):180-8. PubMed ID: 15500667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Analytic research on surface-active agents. II. Conjugated polyoxyethylene glycols].
    IACOBELLI TURI C
    Rend Ist Sup Sanit; 1959; 22():727-46. PubMed ID: 14405748
    [No Abstract]   [Full Text] [Related]  

  • 67. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Mechanism of transesterification of aspirin with polyethyleneglycols (author's transl)].
    Eckert T; Zander M
    Arch Pharm (Weinheim); 1977 Feb; 310(2):136-41. PubMed ID: 849118
    [No Abstract]   [Full Text] [Related]  

  • 69. [About incompatibilities; chemical reactions in powder mixtures].
    ROSENTHALER L
    Pharm Acta Helv; 1946 Jun; 21(5-6):142; 187. PubMed ID: 20277037
    [No Abstract]   [Full Text] [Related]  

  • 70. [The utilization of polyethylene glycols as vehicles in the administration of drugs rectally].
    Ragazzi E; Dalla Fini G; Dal Zotto M
    Boll Chim Farm; 1986 Jul; 125(7):234-49. PubMed ID: 3801166
    [No Abstract]   [Full Text] [Related]  

  • 71. [Polyethylene glycols and their pharmaceutical significance].
    SCHUTZ E
    Arzneimittelforschung; 1953 Sep; 3(9):451-6. PubMed ID: 13093502
    [No Abstract]   [Full Text] [Related]  

  • 72. [Investigations of the light-induced autoxidation of polyethylene glycols (atuhor's transl)].
    Reimann I; Hollatz G; Eckert T
    Arch Pharm (Weinheim); 1974 May; 307(5):328-32. PubMed ID: 4838084
    [No Abstract]   [Full Text] [Related]  

  • 73. Incompatibilities due to synthetic surface-active agents.
    FISHBURN AC
    Chem Drug; 1947 Oct; 148(3528):415. PubMed ID: 20265794
    [No Abstract]   [Full Text] [Related]  

  • 74. [Chemically incompatible drug mixtures; inactivation of tropic acid ester & related compounds by means of basic solvents].
    SOMMER S; VREDEN E; FRIEBEL H
    Arch Pharm Ber Dtsch Pharm Ges; 1957 Jun; 290/62(6):273-6. PubMed ID: 13445126
    [No Abstract]   [Full Text] [Related]  

  • 75. Some Incompatibilities.
    Cassidy JS
    Dent Regist; 1895 Dec; 49(12):608-611. PubMed ID: 33702637
    [No Abstract]   [Full Text] [Related]  

  • 76. [A contribution to the characterization of incompatibilities of drugs with polyethylene glycols and ethoxylated tensides (author's transl)].
    Voigt R; Leuschner S; Bornschein M
    Pharmazie; 1982 Jan; 37(1):22-5. PubMed ID: 7071107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Towards a molecular characterization of pharmaceutical excipients: mass spectrometric studies of ethoxylated surfactants.
    Raith K; Schmelzer CE; Neubert RH
    Int J Pharm; 2006 Aug; 319(1-2):1-12. PubMed ID: 16730931
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
    Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
    Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Contributions to the liberation of drugs from suspension ointments. Part 19: Studies on the interactions of hydroxyquinoline (salts) with ointment components (author's transl)].
    Heber B; Horsch W
    Pharmazie; 1982 Apr; 37(4):277-9. PubMed ID: 7100252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanomedicine: a new paradigm to overcome drug incompatibilities.
    Abdelkader A; Fathi HA; Hamad MA; Elsabahy M
    J Pharm Pharmacol; 2020 Oct; 72(10):1289-1305. PubMed ID: 32436221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.